Penbutolol in black hypertensive patients

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Black patients often exhibit unique responses to antihypertensive medications.
• Non-selective beta-blockers are a class of drugs used to manage high blood pressure.

Purpose of the Study:

• To evaluate the efficacy of penbutolol as a sole antihypertensive agent in black patients.
• To assess the safety and effectiveness of once-daily penbutolol in this specific demographic.

Main Methods:

• A single-blind, placebo-controlled study design.
• Involved a 4-week run-in period followed by a 20-week trial of active medication.
• Included 18 black hypertensive patients receiving daily penbutolol.

Main Results:

• Fourteen out of 18 patients achieved adequate blood pressure control.
• No significant changes in mean heart rates were observed compared to placebo.
• Hypertension recurred in all patients upon cessation of penbutolol therapy.

Conclusions:

• Penbutolol is an effective monotherapy for hypertension in black patients.
• The drug demonstrates a favorable safety profile with no significant impact on heart rate.
• Treatment cessation leads to a return of hypertensive states, underscoring its therapeutic role.